Stock Screener App

Frei -

Installieren

2.35

6.82% -0.18

Lantern Pharma Inc (LTRN)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Lantern Pharma Inc-Aktie (LTRN)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-07-01	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	4.3498	-	4.774	5.8964	5.1796
Operating Income/Loss	-4.3498	-	-4.774	-5.8964	-5.1796
Income/Loss From Continuing Operations Before Tax	3.55% -4.1774	-4.331	-4.5368	-5.8752	-4.5057
Income/Loss From Continuing Operations After Tax	3.55% -4.1774	-4.331	-4.5368	-5.8752	-4.5057
Net Income/Loss	3.55% -4.1774	-4.331	-4.5368	-5.8752	-4.5057
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	10.83	-	10.78	0.0073	10.76
Diluted Average Shares	10.83	-	10.78	0.0073	10.76
Basic Earnings Per Share	-0.39	-	-0.42	-0.54	-0.42
Diluted Earnings Per Share	-0.39	-	-0.42	-0.54	-0.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$46.06

0.41%

ROIV

$28.99

1.33%

MRNA

$54.07

1.61%

BNTX

$90.20

0.16%

INSM

$141.15

1.23%

ONC

$288.30

0.99%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters